Surrozen(SRZN)
$29.98-2.34 (-7.24%)
SRZN
Surrozen financials statements
$29.98
At close:-2.34 (-7.24%)
Want to see SRZN full AI Analyst Report?
Surrozen (SRZN) Ratios
66 Followers
Surrozen Ratios
SRZN's free cash flow for Q3 2026 was $-4.86M. For the 2026 fiscal year, SRZN's free cash flow was decreased by $-27.00K and operating cash flow was $-4.83M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 9.22 | 5.32 | 5.75 | 8.35 | 7.75 |
| Quick Ratio | 9.22 | 5.32 | 5.75 | 8.35 | 7.75 |
| Cash Ratio | 8.99 | 4.73 | 5.04 | 2.54 | 2.44 |
| Solvency Ratio | -0.84 | -0.89 | -5.05 | -2.53 | -1.79 |
| Operating Cash Flow Ratio | -3.05 | -2.41 | -5.65 | -4.54 | -3.60 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -194.93M | $ -30.91M | $ 32.99M | $ 67.87M | $ 77.72M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.17 | 0.07 | 0.06 | 0.06 |
| Debt-to-Equity Ratio | -0.04 | -0.40 | 0.09 | 0.07 | 0.07 |
| Debt-to-Capital Ratio | -0.04 | -0.66 | 0.08 | 0.07 | 0.07 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.53 | -2.27 | 1.21 | 1.18 | 1.25 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.89 | 2.89 | 1.67 | 2.42 | 3.34 |
| Net Debt to EBITDA | 0.34 | 0.42 | 0.79 | 0.45 | 0.49 |
| Profitability Margins | |||||
| Gross Profit Margin | 84.56% | 100.00% | 0.00% | 73.85% | 0.00% |
| EBIT Margin | -6960.77% | -596.56% | 0.00% | -354.71% | 0.00% |
| EBITDA Margin | -6945.33% | -583.03% | 0.00% | -339.07% | 0.00% |
| Operating Profit Margin | -1210.58% | -239.69% | 0.00% | -354.71% | 0.00% |
| Pretax Profit Margin | -6960.77% | -596.56% | 0.00% | -288.03% | 0.00% |
| Net Profit Margin | -6960.77% | -596.56% | 0.00% | -288.03% | 0.00% |
| Continuous Operations Profit Margin | -6960.77% | -596.56% | 0.00% | -288.03% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 96.09% |
| EBT Per EBIT | 574.99% | 248.89% | 94.02% | 81.20% | 100.47% |
| Return on Assets (ROA) | -245.15% | -131.15% | -93.41% | -40.26% | -38.28% |
| Return on Equity (ROE) | 128.90% | 297.31% | -113.46% | -47.37% | -47.87% |
| Return on Capital Employed (ROCE) | -47.40% | -62.06% | -117.59% | -55.63% | -44.01% |
| Return on Invested Capital (ROIC) | -46.72% | -59.42% | -110.50% | -54.12% | -43.24% |
| Return on Tangible Assets | -245.15% | -131.15% | -93.41% | -40.26% | -38.28% |
| Earnings Yield | -143.21% | -151.02% | -226.90% | -178.20% | -23.27% |
| Efficiency Ratios | |||||
| Receivables Turnover | 16.72 | 4.19 | 0.00 | 6.32 | 0.00 |
| Payables Turnover | 0.74 | 0.00 | 51.87 | 4.97 | 1.21 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.54 | 1.27 | 0.00 | 1.81 | 0.00 |
| Asset Turnover | 0.04 | 0.22 | 0.00 | 0.14 | 0.00 |
| Working Capital Turnover Ratio | 0.06 | 0.32 | 0.00 | 0.15 | 0.00 |
| Cash Conversion Cycle | -472.99 | 87.05 | -7.04 | -15.71 | -300.90 |
| Days of Sales Outstanding | 21.83 | 87.05 | 0.00 | 57.76 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 494.82 | 0.00 | 7.04 | 73.47 | 300.90 |
| Operating Cycle | 21.83 | 87.05 | 0.00 | 57.76 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -4.04 | -6.01 | -20.00 | -19.07 | -20.90 |
| Free Cash Flow Per Share | -4.06 | -6.02 | -20.20 | -19.39 | -21.44 |
| Dividend Paid and CapEx Coverage Ratio | -236.28 | -678.00 | -101.41 | -60.64 | -38.47 |
| Capital Expenditure Coverage Ratio | -236.28 | -678.00 | -101.41 | -60.64 | -38.47 |
| Operating Cash Flow Coverage Ratio | -4.56 | -2.08 | -11.95 | -7.88 | -6.26 |
| Operating Cash Flow to Sales Ratio | -8.70 | -1.65 | 0.00 | -3.53 | 0.00 |
| Free Cash Flow Yield | -17.97% | -41.94% | -214.88% | -222.09% | -22.20% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.70 | -0.66 | -0.44 | -0.56 | -4.30 |
| Price-to-Sales (P/S) Ratio | 48.61 | 3.95 | 0.00 | 1.62 | 0.00 |
| Price-to-Book (P/B) Ratio | -0.90 | -1.97 | 0.50 | 0.27 | 2.06 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.56 | -2.38 | -0.47 | -0.45 | -4.51 |
| Price-to-Operating Cash Flow Ratio | -5.59 | -2.39 | -0.47 | -0.46 | -4.62 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | -0.42 | -0.01 | 0.02 | 0.10 |
| Enterprise Value Multiple | -0.36 | -0.26 | 0.33 | -0.03 | -3.90 |
| Enterprise Value | 86.40M | 15.99M | -13.69M | 1.12M | 200.32M |
| EV to EBITDA | -0.36 | -0.26 | 0.33 | -0.03 | -3.90 |
| EV to Sales | 24.85 | 1.50 | 0.00 | 0.09 | 0.00 |
| EV to Free Cash Flow | -2.84 | -0.91 | 0.34 | -0.02 | -4.00 |
| EV to Operating Cash Flow | -2.86 | -0.91 | 0.34 | -0.03 | -4.10 |
| Tangible Book Value Per Share | -25.11 | -7.29 | 18.80 | 32.83 | 46.97 |
| Shareholders’ Equity Per Share | -25.11 | -7.29 | 18.80 | 32.83 | 46.97 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.46 | 3.63 | 0.00 | 5.40 | 0.00 |
| Net Income Per Share | -32.37 | -21.67 | -21.33 | -15.55 | -22.48 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 0.96 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 0.81 | 1.00 |
| Research & Development to Revenue | 8.45 | 1.98 | 0.00 | 2.96 | 0.00 |
| SG&A to Revenue | 4.66 | 1.41 | 0.00 | 1.59 | 0.00 |
| Stock-Based Compensation to Revenue | 1.10 | 0.39 | 0.00 | 0.36 | 0.00 |
| Income Quality | 0.12 | 0.28 | 0.94 | 1.23 | 0.89 |
Currency in USD

